Muscle Strength and Functional Autonomy of Elderly Women

Muscle Strength and Functional Autonomy of Normo-IGF-1 Elderly Women With Skeletal Muscle Dysfunctions

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01553396

Enrollment

Registered

2012-03-14

Start date

2009-01-31

Completion date

2009-04-30

Last updated

2012-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle, Ligament and Fascia Disorders

Brief summary

This study shows an evaluation of the correlation between the muscle strength levels and functional autonomy of elderly women.

Detailed description

The aim of this study was to evaluate the correlation between the muscle strength levels and functional autonomy of elderly women with impaired muscle-skeletal system depending on the normal IGF-1 level. The target-population was composed by elderly women aged between 60 and 75 years (age: 67.79 ± 5.11 years, BMI: 28.01 ± 5.4), residents of an asylum, with IGF-1 levels within the normal values for the age (normo-IGF-1). Evaluations of the muscle strength (1-RM test) and the functional autonomy (GDLAM Protocol) in the performance of activities of daily living (ADL), and a measurement of basal serum levels of IGF-1 (Chemiluminescence method) were performed.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Eligibility

Sex/Gender

FEMALE

Age

60 Years to 75 Years

Healthy volunteers

Inclusion criteria

* present a muscle-skeletal dysfunction, such as osteoporosis, arthritis, tendinitis, but being able to perform their ADL without help from others; * did not practice physical activity for at least 12 months; * provide a normal IGF-1 level for their age;

Exclusion criteria

* elderly women unfit to perform the strength and functional autonomy tests for the medical assessment;

Outcome results